Profile
ABCM NVO VRTX REGN SGEN ARGX
Company Name Abcam plc Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $5.52B $292.61B $105.75B $77.45B $43.15B $38.15B
Employees 1.76K 71.88K 5.40K 14.17K 3.26K 1.15K
CEO Mr. Alan Thomas Hirzel BS, M.B.A., M.S. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
ABCM NVO VRTX REGN SGEN ARGX
Quant Rating Score 3 3 4 3 1
Quant Rating Neutral Neutral Buy Neutral Strong Sell
Trading
ABCM NVO VRTX REGN SGEN ARGX
Last Close $23.99 $87.65 $410.65 $716.68 $228.74 $632.04
High 52 $23.99 $146.91 $516.74 $1201.76 $228.74 $638.33
Low 52 $23.99 $85 $392.81 $701.85 $228.74 $356.01
Price vs. 52 Week High 0 % -40.34 % -20.53 % -40.36 % 0 % -0.99 %
Price vs. 52 Week Low 0 % 3.12 % 4.54 % 2.11 % 0 % 77.53 %
Total Return
ABCM NVO VRTX REGN SGEN ARGX
1 Month Return 0 % -17.41 % -11.6 % -5.06 % 0 % 2.84 %
3 Month Return 0 % -27.42 % -11.28 % -31.27 % 0 % 17.89 %
6 Month Return 0 % -39.34 % -13.09 % -31.8 % 0 % 42.05 %
9 Month Return 0 % -31.55 % -1.6 % -25.83 % 0 % 58.57 %
YTD Return 0 % -15.27 % 0.92 % -18.4 % 0 % 66.14 %
1 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABCM NVO VRTX REGN SGEN ARGX
Dividend Yield Percentage (TTM) - 1.54 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) 1.05 % 1.25 % -2.62 % 4.88 % -2.27 % -2.22 %
Dividend Per Share (TTM) - 9.9 % - - - -
Payout Ratio (TTM) - 46.6 % - - - -
Growth
ABCM NVO VRTX REGN SGEN ARGX
Asset Growth 7.15 % 30.35 % 25.23 % 13.23 % -1.21 % 44.93 %
Gross Profit Growth 20.44 % 32.32 % 9.64 % 6.49 % 22.93 % 190.7 %
Revenue Growth 14.68 % 31.26 % 10.51 % 7.76 % 24.65 % 198.56 %
Revenue 3 Year 26.28 % 90.03 % 60.36 % 55.67 % 91.56 % 2071.96 %
Revenue 5 Year 38.49 % 123.63 % 219.55 % 110.3 % 215.48 % 3041.46 %
Revenue 10 Year 155.91 % 65.69 % 610.45 % 549.62 % 494.04 % 9009.53 %
EBIT Growth -243.66 % 37.11 % 0 % -14.6 % 10.13 % 40.94 %
Net Income Growth -293.18 % 50.71 % 8.96 % -8.87 % 9.51 % 58.42 %
Net Income 3 Yeari Growth Per Share -161.73 % 106.26 % 34.59 % 13.48 % -763.59 % 64.01 %
Net Income 5 Yeari Growth Per Share -112.2 % 133.27 % 70.33 % 74.02 % -276.93 % -143.65 %
Net Income 10 Yeari Growth Per Share -122.5 % 98.1 % 809.6 % 871.12 % -624.16 % -857 %
Operating Income Growth -243.66 % 37.11 % 0 % -14.6 % 10.13 % 40.94 %
Operating Cash Flow Growth (CFG) -54.37 % 38.06 % -14.35 % -8.39 % 9.07 % 51.28 %
Operating 3 Year CFG -58.65 % 117.73 % 9.63 % 76.95 % -147.99 % 21.71 %
Operating 5 Year CFG -59.52 % 162.84 % 174.78 % 125.17 % -195.86 % -329.63 %
Operating 10 Year CFG -37.07 % 150.28 % 6084.35 % 713.56 % -2622.09 % -1280.2 %
EPS Growth -293.75 % 51.88 % 8.33 % -8.54 % 10.81 % 60.46 %
EPS Diluted Growth -293.75 % 52.37 % 8.35 % -9.03 % 10.81 % 60.46 %
Book Value Per Share 10.89 % 28.67 % 25.58 % 15.03 % -9.83 % 38.53 %
Share Holder 3 Year Equity Growth Per Share 31.28 % 74.77 % 104.06 % 137.56 % 33.72 % 93.75 %
Share Holder 5 Year Equity Growth Per Share 84.54 % 121.34 % 291.14 % 219.1 % 220.81 % 318.81 %
Share Holder 10 Year Equity Growth Per Share 269.11 % 49.24 % 1030.79 % 1286.9 % 691.19 % 3654.06 %
Dividend Per Share Growth 0.09 % 26.56 % - - - -
Dividend 3 Year Growth Per Share -9.23 % 63.98 % - - - -
Dividend 5 Year Growth Per Share 1 % 79.57 % - - - -
Dividend 10 Year Growth Per Share 72.85 % 94.94 % - - - -
Debt Growth -2.53 % 4.74 % 44.1 % 0.06 % -23.28 % 60.95 %
Free Cash Flow Growth -506.45 % 9.17 % -16.47 % -17.11 % 3.67 % 51.98 %
Updated On 31 Dec 2022 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
ABCM NVO VRTX REGN SGEN ARGX
Gross Profit Margin TTM 71.21 % 84.66 % 86.1 % 84.42 % 72.37 % 86.82 %
Return on Assets TTM 0.45 % 23.83 % -2.16 % 12.43 % -11.76 % -2.13 %
Return on Equity TTM 0.76 % 86.4 % -2.88 % 16.85 % -16.53 % -2.75 %
Return on Capital Employed TTM 0.8 % 62.74 % -1.72 % 11.85 % -16.87 % -8.98 %
Net Income Per EBT TTM 93.62 % 79.43 % -184.82 % 93.66 % 100.55 % 167.72 %
EBT Per Ebit TTM 73.44 % 100.52 % -82.68 % 124.1 % 94.01 % 15.76 %
EBIT Per Revenue TTM 2.03 % 43.84 % -2.96 % 28.92 % -36.09 % -17.08 %
Cash Flow To Debt Ratio TTM 27.38 % 207.5 % - 214.08 % -185.98 % -
Receivables Turnover TTM - 3.89 6.06 2.27 1.98 3.45
Payables Turnover TTM 7.04 1.72 3.73 4.34 1.54 1.06
Inventory Turnover TTM 1.56 1.09 1.37 0.71 0.65 0.91
Fixed Asset Turnover TTM 195.05 % 225.8 % 422.11 % 311.93 % 256.83 % 6116.64 %
Asset Turnover TTM 31.98 % 68.08 % 47.71 % 36.98 % 34.46 % 47.09 %
Operating Cash Flow Per Share TTM 0.3 26.54 -3.27 39.29 -1.12 -2.42
Free Cash Flow Per Share TTM 0.01 15.14 -4.51 31.25 -1.62 -3.52
Cash Per Share TTM 45.81 % 1681.33 % 2528.88 % 9062.44 % 657.5 % 5163.05 %
Operating Cash Flow Sales Ratio TTM 19.94 % 43.69 % -7.94 % 30.67 % -16.85 % -6.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 4.93 % 57.03 % 138.12 % 79.52 % 144.14 % 145.12 %
Cash Flow Coverage Ratios TTM 27.38 % 207.5 % - 214.08 % -185.98 % -
Price To Free Cash Flows Ratio TTM - 42.16 -90.87 22.93 -141.85 -180.64
Price To Operating Cash Flows Ratio TTM 40.46 24.15 -125.74 18.24 -203.89 -260.94
Price Cash Flow Ratio TTM 40.46 24.15 -125.74 18.24 -203.89 -260.94
Income Statement (TTM)
ABCM NVO VRTX REGN SGEN ARGX
Revenue $0.36B $232.26B $9.87B $13.12B $1.96B $1.23B
Gross Profit $0.27B $196.5B $8.61B $11.3B $1.55B $1.11B
Gross Profit Ratio 74.79% 84.6% 87.21% 86.16% 79.1% 90.39%
EBITDA $0.04B $114.63B $4.61B $4.69B $-0.62B $-0.22B
Net Income $-0.01B $83.68B $3.62B $3.95B $-0.61B $-0.3B
EPS Diluted -0.04 18.62 13.89 34.77 -3.3 -5.16
Balance Sheet (MRQ)
ABCM NVO VRTX REGN SGEN ARGX
Long Term Debt $0.1B $20.53B $1.45B $2.7B $0.04B $0.02B
Total Liabilities $0.33B $207.93B $5.15B $7.11B $0.87B $0.44B
Total Equity $0.73B $106.56B $17.58B $25.97B $2.8B $4.1B
Total Investments $0B $17.5B $3.45B $13.51B $1.42B $1.18B
Total Debt $0.22B $27.01B $0.81B $2.7B $0.04B $0.02B
Total Assets $1.06B $314.49B $22.73B $33.08B $3.67B $4.54B
Cash Flow Statement (TTM)
ABCM NVO VRTX REGN SGEN ARGX
Net Income $-0.01B $83.68B $3.62B $3.95B $-0.61B $-0.43B
Inventory $-0.01B $-7.42B $-0.32B $-0.27B $-0.23B $-0.08B
Dividends Paid $-0.03B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $0.03B $108.91B $3.54B $4.59B $-0.45B $-0.42B
Capital Expenditure $-0.04B $-38.9B $-0.26B $-0.93B $-0.08B $-0.04B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 3.2435
ABCL AbCellera Biologics Inc. 2.95
ABEO Abeona Therapeutics Inc. 5.66
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.81
ABPWW 0.18
ABSI Absci Corporation 2.785
ABUS Arbutus Biopharma Corporation 3.205
ABVC ABVC BioPharma, Inc. 0.6022
ABVX Abivax SA American Depositary Shares 7.2
ACAD ACADIA Pharmaceuticals Inc. 16.97
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.9188
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.13
ACHV Achieve Life Sciences, Inc. 3.66
ACIU AC Immune SA 2.805
ACLX Arcellx, Inc. 78.72
ACRV Acrivon Therapeutics, Inc. Common Stock 5.92
ACST Acasti Pharma Inc. 3.37
ETFs With Exposure to ABCM
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.40175 133.526
SPDW SPDR Portfolio Developed World ex-US ETF 0.033598 34.367
BIB ProShares Ultra Nasdaq Biotechnology 0.189373 51.54
MNA IQ Merger Arbitrage ETF 6.85 33.0001
ONEQ Fidelity Nasdaq Composite Index ETF 0.01 77.6094
FPXI First Trust International Equity Opportunities ETF 0.45 47.5308
ISCF iShares MSCI Intl Small-Cap Multifactor ETF 0.18111 32.2799
MRGR ProShares Merger ETF 3.16608 41.0448
FPXE First Trust IPOX Europe Equity Opportunities ETF 0.27 25.8141
VINEX Vanguard International Explorer Fund Investor Shares 0.22 16.48
VGHAX Vanguard Health Care Fund Admiral Shares 0.36 77.94
VGHCX Vanguard Health Care Fund Investor Shares 0.36 184.87
BMED BlackRock Future Health ETF 1.68229 25.4149
IBBQ Invesco Nasdaq Biotechnology ETF 0.539 21.6761
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.48139 6.074
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.53798 6.319
DFIC Dimensional International Core Equity 2 ETF 0.00052105 25.9497
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.53798 6.321
CTRU ARK Transparency ETF 0.96 12.897
Unlock